Nanopore Biosensor for Kinetics of Reparative Antibodies on Plasma Membranes

用于质膜上修复抗体动力学的纳米孔生物传感器

基本信息

  • 批准号:
    8475616
  • 负责人:
  • 金额:
    $ 39.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-06-01 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The capability to perform in vitro, label-free dynamic assays for membrane-bound antigens is a highly desired task, but is rarely achieved using standard commercialized technology such as BIAcoreTM. The problem is compounded for transmembrane proteins such as G protein coupled receptors (GPCR) because proteins in direct contact with a solid substrate, in particular with the gold substrate used in BIAcoreTM, often lose their functionality or denature. The nanopore- sensing architecture proposed here has the unique potential to overcome these challenges, since each nanopore sits on a glass substrate and forms a tiny well to confine the supported lipid membranes, while the surrounding gold film provides surface plasmon resonance effects to dynamically monitor binding of molecules onto the membrane. This proposal will validate these membrane biosensing concepts by characterizing the binding of therapeutic human monoclonal antibodies to candidate antigens. These human IgMs promote remyelination of demyelinated lesions and preserve axons. These are ideal molecules in which to test this system because the IgM antigen binding appears to require an intact membrane environment. A major challenge in moving these reparative IgMs to clinical trial is to understand the kinetics of binding to the cell-surface antigens. Our hypothesis and preliminary data suggests that the mAbs do not bind to a single membrane molecule, but to a signaling complex within lipid micro-domains (lipid rafts) of cells. If this complex is disrupted, mAb binding is eliminated. The IgMs maintain their cell specificity only when bound to intact plasma membranes. Fixation of any kind (methanol, formaldehyde, freezing) destroys the complex membrane antigen. When candidate antigens are presented in isolated form, the IgMs bind non-specifically to all or to none. Therefore, it is important to maintain the cell membrane antigens in their native state to preserve appropriate mAb binding kinetics. A new antigen screening technology is required to study these difficult but critical lipid and carbohydrate molecules of the plasma membrane. Unfortunately, there are no label-free kinetic screening and quantification methods to measure the binding affinity between cell plasma membranes and mAbs. The commercial BIAcore" instrument - currently the gold standard for measuring binding kinetics - works with purified molecules, primarily proteins, immobilized on a gold film substrate. However, this instrument is not suitable for quantification of interactions between mAbs and cell-surface antigens in their native membrane inserted state. We propose here to use a novel instrument, a nano-LAMP (LAser-illuminated Metallic Pore) array, to quantify the binding kinetics of mAbs to antigens anchored within a cell membrane at a high spatial resolution. We have validated this platform with membrane-free systems and with artificial membranes for binding kinetics measurements. The work proposed here will further optimize the platform by reconstituting oligodendrocytes and neuronal cell membranes on metallic nanopores to measure and quantify their binding affinity with human therapeutic IgMs, to identify candidate antigens. Once developed, this technology will likely prove important in the study of complex molecular interactions and signals transduced by cell receptors. As a future direction, we also propose the possibility of reconstituting free-standing lipid membranes hanging over a free-standing metallic nanopore substrate, incorporating transmembrane proteins such as GPCRs, and demonstrating the feasibility of kinetic sensing with an artificial membrane system that can integrate transmembrane proteins in contact with a buffer solution on both sides.
描述(由申请人提供):对膜结合的抗原进行体外,无标签的动态测定的能力是一项高度期望的任务,但很少使用标准商业化技术(例如Biacoretm)实现。该问题对于跨膜蛋白(例如G蛋白偶联受体(GPCR))而更复杂,因为与固体底物直接接触的蛋白,尤其是与biacoretm中使用的金底物,通常会失去其功能或剥夺。此处提出的纳米孔感应架构具有克服这些挑战的独特潜力,因为每个纳米孔都位于玻璃基板上,并形成了一个微小的良好,以限制受支持的脂质膜,而周围的金膜则提供表面等离子体的谐振效果,以使分子在膜上的结合到膜上。该建议将通过表征治疗性人类单克隆抗体与候选抗原的结合来验证这些膜生物传感概念。这些人类IgM促进了脱髓鞘病变并保存轴突的再髓。这些是测试该系统的理想分子,因为IgM抗原结合似乎需要完整的膜环境。将这些修复性IgM转移到临床试验的主要挑战是了解与细胞表面抗原结合的动力学。我们的假设和初步数据表明,mAb不与单个膜分子结合,而是与细胞脂质微层(脂质筏)内的信号传导复合物结合。如果该复合物被破坏,则消除了mAb结合。仅当与完整的质膜结合时,IgM才能保持其细胞特异性。任何种类的固定(甲醇,甲醛,冷冻)会破坏复杂的膜抗原。当候选抗原以孤立形式呈现时,IgMS与所有或无特异性结合。因此,将细胞膜抗原保持在其天然状态很重要,以保留适当的mAb结合动力学。需要一种新的抗原筛选技术来研究质膜的这些困难但关键的脂质和碳水化合物分子。不幸的是,没有无标签的动力学筛选和定量方法来测量细胞质膜和mAb之间的结合亲和力。商业biacore“仪器 - 目前是测量结合动力学的金标准 - 与纯化的分子(蛋白质是蛋白质)一起起作用,固定在黄金膜底物上。但是,该仪器主要不适合量化mabs和细胞表面抗原之间的相互作用。为了量化在高空间分辨率的细胞膜内的mAb的结合动力学,我们已经用无膜系统验证了这个平台,并使用人工膜进行了人工膜,以实现在此处提出的工作,以进一步调整量子的范围。与人类治疗的IgM相结合,一旦开发了候选抗原,这项技术可能会在研究复杂的分子相互作用和细胞受体转导的信号中很重要。通过人造膜系统展示动力学传感的可行性,该系统可以整合跨膜蛋白与两侧的缓冲溶液接触。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ultrasmooth metallic films with buried nanostructures for backside reflection-mode plasmonic biosensing.
  • DOI:
    10.1002/andp.201200144
  • 发表时间:
    2012-11
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    Lindquist, Nathan C.;Johnson, Timothy W.;Jose, Jincy;Otto, Lauren M.;Oh, Sang-Hyun
  • 通讯作者:
    Oh, Sang-Hyun
Millimeter-Sized Suspended Plasmonic Nanohole Arrays for Surface-Tension-Driven Flow-Through SERS.
  • DOI:
    10.1021/cm5031848
  • 发表时间:
    2014-11-25
  • 期刊:
  • 影响因子:
    8.6
  • 作者:
    Kumar, Shailabh;Cherukulappurath, Sudhir;Johnson, Timothy W.;Oh, Sang-Hyun
  • 通讯作者:
    Oh, Sang-Hyun
Lipid Membrane Deformation Accompanied by Disk-to-Ring Shape Transition of Cholesterol-Rich Domains.
  • DOI:
    10.1021/jacs.5b04559
  • 发表时间:
    2015-07
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Yong-Sang Ryu;Daehan Yoo;Nathan J. Wittenberg;Luke R. Jordan;S. Lee;A. Parikh;Sang-Hyun Oh
  • 通讯作者:
    Yong-Sang Ryu;Daehan Yoo;Nathan J. Wittenberg;Luke R. Jordan;S. Lee;A. Parikh;Sang-Hyun Oh
Reconstituting ring-rafts in bud-mimicking topography of model membranes.
  • DOI:
    10.1038/ncomms5507
  • 发表时间:
    2014-07-24
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Ryu, Yong-Sang;Lee, In-Ho;Suh, Jeng-Hun;Park, Seung Chul;Oh, Soojung;Jordan, Luke R.;Wittenberg, Nathan J.;Oh, Sang-Hyun;Jeon, Noo Li;Lee, Byoungho;Parikh, Atul N.;Lee, Sin-Doo
  • 通讯作者:
    Lee, Sin-Doo
Atomic layer deposition (ALD): A versatile technique for plasmonics and nanobiotechnology.
  • DOI:
    10.1557/jmr.2011.434
  • 发表时间:
    2012-02-28
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Im H;Wittenberg NJ;Lindquist NC;Oh SH
  • 通讯作者:
    Oh SH
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sang-Hyun Oh其他文献

Sang-Hyun Oh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sang-Hyun Oh', 18)}}的其他基金

Nanopore Biosensor for Kinetics of Reparative Antibodies on Plasma Membranes
用于质膜上修复抗体动力学的纳米孔生物传感器
  • 批准号:
    7857498
  • 财政年份:
    2010
  • 资助金额:
    $ 39.13万
  • 项目类别:
Nanopore Biosensor for Kinetics of Reparative Antibodies on Plasma Membranes
用于质膜上修复抗体动力学的纳米孔生物传感器
  • 批准号:
    8079542
  • 财政年份:
    2010
  • 资助金额:
    $ 39.13万
  • 项目类别:
Nanopore Biosensor for Kinetics of Reparative Antibodies on Plasma Membranes
用于质膜上修复抗体动力学的纳米孔生物传感器
  • 批准号:
    8299585
  • 财政年份:
    2010
  • 资助金额:
    $ 39.13万
  • 项目类别:

相似国自然基金

人源化小鼠筛选猴痘抗体及机制研究
  • 批准号:
    82373778
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
  • 批准号:
    82302487
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
  • 批准号:
    32371262
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
  • 批准号:
    82371845
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
  • 批准号:
    32300783
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
  • 批准号:
    10727268
  • 财政年份:
    2023
  • 资助金额:
    $ 39.13万
  • 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
  • 批准号:
    10660332
  • 财政年份:
    2023
  • 资助金额:
    $ 39.13万
  • 项目类别:
Project 1: The impact of innate immune responses on the development of broadly neutralizing antibodies by vaccination
项目 1:先天免疫反应对通过疫苗接种产生广泛中和抗体的影响
  • 批准号:
    10731281
  • 财政年份:
    2023
  • 资助金额:
    $ 39.13万
  • 项目类别:
Characterizing molecular phenotypes of pancreatic islet reactive B cells in T1D through single cell sequencing
通过单细胞测序表征 T1D 中胰岛反应性 B 细胞的分子表型
  • 批准号:
    10600510
  • 财政年份:
    2023
  • 资助金额:
    $ 39.13万
  • 项目类别:
A synthetic biosensor of immunologic synapse formation allowing multiplexed T cell antigen discovery for autoimmune neurologic disorders
一种免疫突触形成的合成生物传感器,可发现自身免疫性神经系统疾病的多重 T 细胞抗原
  • 批准号:
    10740610
  • 财政年份:
    2023
  • 资助金额:
    $ 39.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了